Patents by Inventor Ning Tian

Ning Tian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11108177
    Abstract: An electrical card connector includes an insulative housing defining a receiving space with a plurality of contacts retained therein with constant pitch thereof. The housing includes a base and a plurality of tongues extending from the base into the receiving space. The contact includes a contact arm extending forwardly into the receiving space, and a soldering leg extending rearwardly out of the base. The tongue includes a plurality of partition bars with corresponding cavities therebetween. The contacts include a plurality of differentia pairs and grounding contacts alternately arranged with each other. The partition bars are located between the neighboring grounding contacts and differential pairs while no partition bar is located within each differential pair.
    Type: Grant
    Filed: March 26, 2020
    Date of Patent: August 31, 2021
    Assignees: FOXCONN (KUNSHAN) COMPUTER CONNECTOR CO., LTD., FOXCONN INTERCONNECT TECHNOLOGY LIMITED
    Inventors: Zhi-Jian Chen, Ning Tian, Kun Huang
  • Publication number: 20210264216
    Abstract: The present invention discloses a visual relationship detection method based on a region-aware learning mechanism, comprising: acquiring a triplet graph structure and combining features after its aggregation with neighboring nodes, using the features as nodes in a second graph structure, and connecting in accordance with equiprobable edges to form the second graph structure; combining node features of the second graph structure with features of corresponding entity object nodes in the triplet, using the combined features as a visual attention mechanism and merging internal region visual features extracted by two entity objects, and using the merged region visual features as visual features to be used in the next message propagation by corresponding entity object nodes in the triplet; and after a certain number of times of message propagations, combining the output triplet node features and the node features of the second graph structure to infer predicates between object sets.
    Type: Application
    Filed: August 31, 2020
    Publication date: August 26, 2021
    Inventors: Anan LIU, Hongshuo TIAN, Ning XU, Weizhi NIE, Dan SONG
  • Patent number: 11090272
    Abstract: It relates to a lurasidone solid dispersion and a preparation method, wherein the method comprises melting treatment of a mixture containing lurasidone, a medicinal hot melt carrier, optionally an acidic regulator and plasticizer in order to obtain the solid dispersion described herein, and wherein the lurasidone is provided in a form of free base. The lurasidone solid dispersion obtained by the preparation method according to the example of the invention has the characteristics of high dissolution rate (dissolution rate can reach 30%-70%) in a partial neutral medium (e.g. pH6.0). The bioavailability of lurasidone solid dispersion increased significantly and the food effect of lurasidone solid dispersion prepared from the example decreased remarkably.
    Type: Grant
    Filed: January 4, 2018
    Date of Patent: August 17, 2021
    Assignee: Sunshine Lake Pharma Co., Ltd.
    Inventors: Yuzhen Xu, Ning Tian, Xin Huang, Jinsong You, Fangfang Huang
  • Publication number: 20200313325
    Abstract: An electrical card connector includes an insulative housing defining a receiving space with a plurality of contacts retained therein with constant pitch thereof. The housing includes a base and a plurality of tongues extending from the base into the receiving space. The contact includes a contact arm extending forwardly into the receiving space, and a soldering leg extending rearwardly out of the base. The tongue includes a plurality of partition bars with corresponding cavities therebetween. The contacts include a plurality of differentia pairs and grounding contacts alternately arranged with each other. The partition bars are located between the neighboring grounding contacts and differential pairs while no partition bar is located within each differential pair.
    Type: Application
    Filed: March 26, 2020
    Publication date: October 1, 2020
    Inventors: ZHI-JIAN CHEN, NING TIAN, KUN HUANG
  • Publication number: 20190321304
    Abstract: It relates to a lurasidone solid dispersion and a preparation method, wherein the method comprises melting treatment of a mixture containing lurasidone, a medicinal hot melt carrier, optionally an acidic regulator and plasticizer in order to obtain the solid dispersion described herein, and wherein the lurasidone is provided in a form of free base. The lurasidone solid dispersion obtained by the preparation method according to the example of the invention has the characteristics of high dissolution rate (dissolution rate can reach 30%-70%) in a partial neutral medium (e.g. pH6.0). The bioavailability of lurasidone solid dispersion increased significantly and the food effect of lurasidone solid dispersion prepared from the example decreased remarkably.
    Type: Application
    Filed: January 4, 2018
    Publication date: October 24, 2019
    Applicant: SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Yuzhen XU, Ning TIAN, Xin HUANG, Jinsong YOU, Fangfang HUANG
  • Publication number: 20170261774
    Abstract: A light curing device comprises a conveyor belt and a light source provided above the conveyor belt. A positioning block is provided on at least a portion, which is parallel to a conveying direction of the conveyor belt, of a carrying surface of the conveyor belt, and the positioning block includes a positioning surface which is perpendicular to the carrying surface of the conveyor belt and extends along the conveying direction of the conveyor belt. The positioning surface is configured to position an object to be conveyed.
    Type: Application
    Filed: July 29, 2016
    Publication date: September 14, 2017
    Inventors: Guowei CHEN, Ning TIAN, Chengchao LI, Wenjun JI
  • Publication number: 20160051685
    Abstract: A 5?-androstane-3?,5,6?-triol injection and its preparation are disclosed. The injection uses hydroxypropyl-?-cyclodextrin as a solubilizing agent and the active ingredient is present at a weight ratio of 1-20:40-500 to the hydroxypropyl-?-cyclodextrin. The injection may also comprise, by weight, 1-100 parts of at least one isotonic adjusting agent, 0-200 parts of at least one freeze drying filler, and 0-2000 parts of at least one solvent. The preparation method comprises dissolving hydroxypropyl-?-cyclodextrin solution, 5?-androstane-3?,5,6?-triol and at least one additional soluble excipient in water for injection in sequence to obtain a raw injection solution, and subjecting the raw injection solution to decolorization, depyrogenation, filtration and sterilization to obtain the injection. Drying the filtrate yields a solid for injection.
    Type: Application
    Filed: August 28, 2015
    Publication date: February 25, 2016
    Applicant: Guangzhou Cellprotek Pharmaceutical LTD.
    Inventors: Guangmei Yan, Haiyan HU, Jingxia ZHANG, Pengxin QIU, Ling LI, Ning TIAN
  • Patent number: 9265837
    Abstract: A 5?-androstane-3?,5,6?-triol injection and its preparation are disclosed. The injection uses hydroxypropyl-?-cyclodextrin as a solubilizing agent and the active ingredient is present at a weight ratio of 1-20:40-500 to the hydroxypropyl-?-cyclodextrin. The injection may also comprise, by weight, 1-100 parts of at least one isotonic adjusting agent, 0-200 parts of at least one freeze drying filler, and 0-2000 parts of at least one solvent. The preparation method comprises dissolving hydroxypropyl-?-cyclodextrin solution, 5?-androstane-3?,5,6?-triol and at least one additional soluble excipient in water for injection in sequence to obtain a raw injection solution, and subjecting the raw injection solution to decolorization, depyrogenation, filtration and sterilization to obtain the injection. Drying the filtrate yields a solid for injection.
    Type: Grant
    Filed: August 28, 2015
    Date of Patent: February 23, 2016
    Assignee: Guangzhou Cellprotek Pharmaceuticals Ltd.
    Inventors: Guangmei Yan, Haiyan Hu, Jingxia Zhang, Pengxin Qiu, Ling Li, Ning Tian
  • Patent number: 9161985
    Abstract: A 5?-androstane-3?,5,6?-triol injection and its preparation are disclosed. The injection uses hydroxypropyl-?-cyclodextrin as a solubilizing agent and the active ingredient is present at a weight ratio of 1-20:40-500 to the hydroxypropyl-?-cyclodextrin. The injection may also comprise, by weight, 1-100 parts of at least one isotonic adjusting agent, 0-200 parts of at least one freeze drying filler, and 0-2000 parts of at least one solvent. The preparation method comprises dissolving hydroxypropyl-?-cyclodextrin solution, 5?-androstane-3?,5,6?-triol and at least one additional soluble excipient in water for injection in sequence to obtain a raw injection solution, and subjecting the raw injection solution to decolorization, depyrogenation, filtration and sterilization to obtain the injection, Drying the filtrate yields a solid for injection.
    Type: Grant
    Filed: July 8, 2011
    Date of Patent: October 20, 2015
    Assignee: Guangzhou Cellprotek Pharmaceutical Ltd.
    Inventors: Guangmei Yan, Halyan Hu, Jingxia Zhang, Pengxin Qiu, Ling Li, Ning Tian
  • Publication number: 20130172414
    Abstract: A pharmaceutical composition comprising levocarnitine and dobesilate is provided. Also provided are a method for regulating the level of serum creatinine and/or blood urea nitrogen and a method for treating and/or preventing the diseases influencing renal function, for example, including but not limiting to various primary, secondary nephritis, renal lesions, renal insufficiency, nephritic syndrome, even renal failure, uremia, as well as the complications induced by the diseases and/or disorders influencing renal function for example, such as cardiovascular diseases, diabetes and the like.
    Type: Application
    Filed: June 10, 2011
    Publication date: July 4, 2013
    Applicants: TIANJIN NANKAI SHARE PHARMACEUTICAL SCIENCE & TECHNOLOGY CO., LTD., XIZANG LINZHI PARKSON PHARMACEUTICAL CO., LTD., NANKAI SHARE PHARMACEUTICAL CO., LTD., LIAONING SEBEST PHARMACEUTICL CO., LTD.
    Inventors: Yong Wang, Xin Zhao, Mo Chen, Ning Tian
  • Publication number: 20130172307
    Abstract: A 5?-androstane-3?,5,6?-triol injection and its preparation are disclosed. The injection uses hydroxypropyl-?-cyclodextrin as a solubilizing agent and the active ingredient is present at a weight ratio of 1-20:40-500 to the hydroxypropyl-?-cyclodextrin. The injection may also comprise, by weight, 1-100 parts of at least one isotonic adjusting agent, 0-200 parts of at least one freeze drying filler, and 0-2000 parts of at least one solvent. The preparation method comprises dissolving hydroxypropyl-?-cyclodextrin solution, 5?-androstane-3?,5,6?-triol and at least one additional soluble excipient in water for injection in sequence to obtain a raw injection solution, and subjecting the raw injection solution to decolorization, depyrogenation, filtration and sterilization to obtain the injection, Drying the filtrate yields a solid for injection.
    Type: Application
    Filed: July 8, 2011
    Publication date: July 4, 2013
    Inventors: Guangmei Yan, Halyan Hu, Jingxia Zhang, Pengxin Qiu, Ling Li, Ning Tian